Millipore Mobius Flexready Smart System TFF with Computer & Cables
Millipore
Details
-
CategoryBioprocessing
-
Dimension42.0in x 89.0in x 79.0in
-
SerialF1BB27271
-
Shipping TypeFreight
-
ManufacturingDoes Not Apply
-
Voltage / Hertz120V/220V / 50Hz/60Hz
Description
The Millipore Mobius Flexready Smart System TFF is a versatile and innovative solution designed for tangential flow filtration (TFF) applications in biopharmaceutical processing. This Fair-conditioned unit, though experiencing minor cosmetic blemishes, is equipped with a computer and power/data cables, enabling a comprehensive setup. Engineered for maximum adaptability with single-use flowpaths, it features optimally designed Flexware assemblies for efficient filtration of monoclonal antibodies, therapeutic proteins, and vaccines. Despite needing user credentials for full testing, it includes a touch screen interface for intuitive operation. The system's specifications, such as a novel retentate recycle tank and constant DP operation, ensure high-volume productivity and reduced contamination risk.
Technician comment
Need user credentials to log on and fully test. (Flex Ready Smart Cart front right caster is damaged & bent, cosmetic damage on smart cart bottom panel.)
Key Features
- Single-use Flexware assemblies
- Pre-assembled and pre-tested system
- Touch screen interface
- Pellicon cassettes for protein filtration
- Adaptable to changing process needs
Specifications
- Voltage: 120V/220V
- Frequency: 50Hz/60Hz
- Retentate recycle tank with magnetic impeller
- Integrated transfer pump for fed batch operations
- Constant DP and constant feed flow operation
Weight
Imperial: 2400.0 Pounds
Metric: 1088.62 Kilograms
Shipping Dimensions
Imperial: 50.4 lb x 106.8 lb x 94.8 lb
Metric: 128.02 cm x 271.27 cm x 240.79 cm
Harmonized Code
84212900
Harmonized Code Details
Harmonized code 84212900 covers machinery for filtering or purifying liquids. This code was chosen because the system is primarily used for tangential flow filtration of biological solutions in the biopharmaceutical industry.
Comments 0
There are currently no public comments.